SBIR

The Commercialization Funding Coach, Fred Patterson, Weighs In On SBIR Funding for Small Business Ventures in Wake of NIH Exclusion

The Commercialization Funding Coach, Inc. proprietor, Fred Patterson, has weighed in on the future of SBIR grants in Washington, DC as a means of funding for small business ventures in the wake of SBIR grants being explicitly excluded from NIH stimulus money. Federal reauthorization or a continui...

NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases

Cambridge, MA October 2, 2007 Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening...

GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite

...ogy company, today announced that it has been awarded a grant to develop an integrated systems pharmacology platform for pharmacogenomic research. The sbir grant, funded through the innovations in biomedical computational science and technology initiative, will be used to develop a database and systems bi...

Cardin Calls on NIH to Utilize Small Businesses for Extramural Research Projects

...g was exempted from mandatory participation in the sbir and Small Business Technology Transfer (STTR) prog... opportunity to receive upwards of $200 million in sbir and STTR grants. "The sbir program is exactly the type of jumpstart that our ...

Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimer's

...at strategies that promote non-amyloidogenic/alpha-secretase APP processing may have significant potential for the treatment of AD," said Tan. This sbir grant, the most recent of three NIH grants, allows the continuing development of TeaMem and its evaluation in the test tube (in vitro). The latest gra...

ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference

...r products based on its platform technology involving targeting of RNA transcription. Funding for the study was obtained in part from a Small Business sbir grant recently awarded to ImQuest by the NIH. ImQuest BioSciences Inc. , a privately held U.S. company located in Frederick, Maryland, is a lead...

Pressure BioSciences, Inc. Provides Corporate Update

...) Outstanding Manuscript Award. 1) Phase I sbir Grant Award: PBI was recently notified by the Nat...ID") of the NIH that it had been awarded a Phase I sbir grant (1R43A1081518-01) for a total of $109,998 to...samples in the study for analysis. If the Phase I sbir studies are successful, the Company expects to sub...

BioNanomatrix Awarded Phase II NIH Grant to Support Development of Its Single-Molecule Nanoscale Whole Genome Analyzer

... - New $2.1 Million sbir Grant Extends NHGRI Support for Commercial Development of the Company's Revolutionary Whole Genome Imaging and Analysis Platform - PHILADELPHIA, ...

NIH Awards a Phase I Small Business Innovative Research Grant on "Novel Laser Scanning Technology for Computed Radiography" to VIXAR and iCRco

...The National Institutes of Health has awarded iCRco partner Vixar a Phase I sbir grant to develop a red VCSEL array assembly for the readout of images in co...The National Institutes of Health has awarded iCRco partner Vixar a Phase I sbir grant to develop a red VCSEL array assembly for the readout of images in co...

Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant

...nership between Sanaria and UMBI supported by this sbir grant is an ideal example of public-private partne...lly for over US $12 million in peer-reviewed NIAID sbir grants. The sbir grants and our other grants are providing more tha...

SBIR in Medical Technology

ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent

FREDERICK, Md., April 21 /PRNewswire/ -- ImQuest BioSciences and Arisyn Therapeutics jointly announced today the successful acquisition of funding from the National Institutes of Health to support the development of novel small molecule therapeutics for the treatment of hepatitis C virus (HCV) inf...

ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide

FREDERICK, Md., July 29 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual tra...

Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery

SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" and "the Company") today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant (2R44GM079059-02) from the National Institutes of Health (NIH). The G...

Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology

MENLO PARK, Calif., Jan. 16 /PRNewswire/ -- Fundamental Applied Biology, Inc. (FAB) announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase IIB grant from the National Science Foundation. The $500,000 grant will be used to continue to develop FAB's cell-free ...

PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies

...es exist for these cancers. Based on promising in vivo and in vitro efficacy data, PDS Biotechnology Corporation was awarded in August 2008, a phase I sbir grant by the US National Institutes of Health/National Cancer Institute to develop Versamune(TM)-Melanoma to treat melanoma, which is the most aggress...

Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System

...warded through the Small Business Innovation Research (SBIR) program of the National Heart, Lung and Blood Institute (NHLBI) of NIH. This is the third sbir grant for Live Recovery Systems from NHLBI. The two previous grants totaling $1.3 million were to develop the ThermoSuit System. Twenty patients wil...

Small Business Innovation Research Program Awards Grant to Biomoda

...ther validates the potential of our innovative technology, particularly the broad-scale benefits expected to accrue from its commercialization." The sbir and SBTT's Phase 0 Program provides technology businesses with the opportunity to propose innovative ideas that match research and development needs o...

GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer

...Newswire/ -- GeneGo, Inc., a leading provider of databases, software and services in systems biology, announced today that they were awarded a Phase I sbir from National Cancer Institute (NCI) for the development of a platform for functional data analysis in cancer. GeneGo will collaborate with investigat...

Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis

...d associated morbidity and mortality." About the sbir Grant The Small Business Innovation Research (SB...r commercialization. Some of the objectives of the sbir Program include using small businesses to stimulat...alization of innovations developed through Federal sbir Research and Development funding. "The...

Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans

...or to joining Clinsys, Dr. Oh served as Director, Medical Affairs, for a global CRO. He also assisted with development of a commercialization plan for sbir and NIH grants for a functional MRI analysis and data management system at several start-up companies. Dr. Oh, who received his MD from Temple Univers...

SBIR in Biological News

NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays

Cambridge, MA January 7, 2009 Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,250,369 Phase II Small Business Innovation Research Grant (SBIR) from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) to develop in vivo zebra...

Lyncean Technologies Inc. receives $1.2 M from NCRR to develop new imaging technique

... Lyncean Technologies, Inc. has just received a Phase I sbir grant of $1,296,403 from the National Center for Research Resources (NCRR) to develop "Differential Phase Contrast Imaging" using the unique x-ray bea...

Exciting new companies at NJIT's small biz incubator get 100K in grants

... The New Jersey Commission on Science and Technology has awarded almost $100,000 as part of its sbir bridge grant program to two start-up companies based in NJIT's high technology business incubator. Applechem Inc. www.applechem.biz and Lenterra ...

Exciting new companies at NJIT's small biz incubator get 100K in lrants

... The New Jersey Commission on Science and Technology has awarded almost $100,000 as part of its sbir bridge grant program to two start-up companies based in NJIT's high technology business incubator. Applechem Inc. www.applechem.biz and Lenterra ...

SBIR in Biological Technology

Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics

GAITHERSBURG, Md., July 22 /PRNewswire/ -- Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has received an SBIR (small business innovation research) grant from National Cancer Institute (NCI), National Institute of Health (NIH), for its novel siRNA therapeutics to treat...

Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609

ROCKVILLE, Md., Feb. 17 /PRNewswire/ -- Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, today announced the receipt of a Small Business Innovation Research (SBIR) Phase I Grant from the National Institute of Allergy and Infectious Diseases (NIA...

Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation

OMAHA, Neb., Nov. 20 /PRNewswire-FirstCall/ -- Transgenomic (OTC Bulletin Board: TBIO) today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) award by the National Science Foundation (NSF) to support the development of its proposed SURVEYOR Endonuclease Adapto...

Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics

GAITHERSBURG, Md., Oct. 28 /PRNewswire/ -- Sirnaomics, Inc. (http://www.sirnaomics.com ) announced today that the company has received an SBIR (small business innovation research) grant from National Cancer Institute (NCI), National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceut...

ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410

FREDERICK, Md., July 9 /PRNewswire/ -- ImQuest Life Sciences announced today the successful acquisition of funding from the National Institutes of Health to define the mechanism of action of their dual-acting pyrimidinedione HIV inhibitor IQP-0410. The objective of this one-year Small Business...

Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development

IRVINE, Calif., July 3 /PRNewswire/ -- Antigen Discovery Inc. ("ADI", formerly ImmPORT Therapeutics Inc.), a leader in high throughput antigen/biomarker discovery using advanced genomics and proteomics tools, announced today that the Company was awarded a Phase II SBIR from the National Instit...

StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform

MENLO PARK, Calif., May 14 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing clinical systems for Enabling Regenerative Medicine(TM), announced today that it has been awarded a National Institutes of Health Phase I Small Business Innovation Research (SBIR) Grant entitl...

Genomas Awarded $1.2 Million NIH SBIR Grant to Develop DNA-Guided System for Management of Statin Therapy

HARTFORD, Conn., March 19 /PRNewswire-FirstCall/ -- Genomas(R), a biomedical company advancing DNA-guided medicine and personalized healthcare, today announced the award of a Fast-Track Phase I-II Small Business Innovation Research (SBIR) Grant totaling $1.2 million. The grant, entitled "DNA D...

Compendia Bioscience Announces the Receipt of a $2.4M SBIR Award and Related Management Changes

ANN ARBOR, Mich., Oct. 11 /PRNewswire/ -- Compendia Bioscience, Inc. today announced the receipt of a $2.4 million SBIR Fast Track Award from the National Cancer Institute to support the project entitled "Development of Oncomine Professional as a Platform for Biopharmaceutical Research and Dev...

Platypus Tech fights cancer with $400,000 SBIR grant

MADISON Platypus Technologies recently announced it received a Phase I small business innovation research (SBIR) grant for $400,000 from the National Cancer Institute . The grant, according to chief executive officer Barbara Israel, is to develop a new method to rapidly measure the activity ...

More>>